U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording losses in today’s session.
- Castle Biosciences, Inc. CSTL shares dipped 48% to $11.80. Baird, SVB Securities and Lake Street lowered their price targets on the stock.
- EPAM Systems, Inc. EPAM dropped 17.7% to $213.50 after the company cut its second-quarter financial outlook.
- Amyris, Inc. AMRS fell 16.2% to $0.7885. Amyris initiated strategic transformation program and secured funding to deliver the company's planned cost reduction target of approximately $250 million from cost of goods sold.
- Comtech Telecommunications Corp. CMTL declined 13.7% to $10.64.
- DMC Global Inc. BOOM dropped 13.6% to $15.65.
- SunCar Technology Group Inc. SDA fell 13.2% to $20.22.
- Gannett Co., Inc. GCI dropped 12.7% to $1.9650.
- Zumiez Inc. ZUMZ fell 11.1% to $13.76. Zumiez recently posted a wider-than-expected quarterly loss.
- IGM Biosciences, Inc. IGMS dipped 10.9% to $12.11. Wedbush reiterated IGM Biosciences with an Outperform and maintained a $37 price target.
- Endava plc DAVA fell 10.8% to $45.97. Needham reiterated Endava with a Buy and maintained a $68 price target.
- Grid Dynamics Holdings, Inc. GDYN declined 10.6% to $8.77.
- Stitch Fix, Inc. SFIX dropped 10.3% to $3.5250.
- 8x8, Inc. EGHT fell 9.5% to $3.80. 8x8 appointed Samuel Wilson as CEO.
- Metals Acquisition Corp MTAL declined 8.9% to $10.38.
- Cipher Mining Inc. CIFR fell 8.7% to $2.3550.
- Globant SA GLOB slipped 8.6% to $172.32.
- CPI Card Group Inc. PMTS fell 8% to $25.13. CPI Card Group said President and CEO Scott Scheirman will retire in 2024 effective Feb. 28, 2024.
- Enovix Corporation ENVX dropped 7.7% to $13.16.
- Lexicon Pharmaceuticals, Inc. LXRX fell 7.7% to $2.5350.
- Blueprint Medicines Corporation BPMC dipped 6.8% to $54.24. SVB Leerink downgraded Blueprint Medicines from Market Perform to Underperform and lowered the price target from $48 to $43.
- PetMed Express, Inc. PETS dropped 5.5% to $14.79.
Read More: HP, Alphabet And 2 Other Stocks Insiders Are Selling
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in